Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra
política de cookies.
Necesarias para navegar en este sitio y utilizar sus funciones. Identificarle como usuario y almacenar sus preferencias como idioma y moneda. Personalizar su experiencia en base con su navegación.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Cookies de terceros con propósitos analíticos. Mostrar recomendaciones personalizadas basadas en su navegación en otros sitios. Mostrar campañas personalizadas en otros sitios web.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
CONCEPT-IC – Modelo de datos (0.1.0)
Raúl Quirós-López, Nicolás Jiménez-García, Eduardo Millán-Ortuondo, & Francisco Estupiñán-Romero. (2022). CONCEPT-IC – Modelo de datos (0.1.0) [Data set]. Zenodo.
PHIRI APP – WP7 – PHIRI Federated Research Infrastructure (FRI) – D7.1 Small-scale prototype of PHIRI federated infrastructure (2.2.4)
Javier González-Galindo, Francisco Estupiñán-Romero, David Chichell-Ruíz, Juan González-García, Carlos Tellería-Orriols, & Enrique Bernal-Delgado. (2022). PHIRI APP – WP7 – PHIRI Federated Research Infrastructure (FRI) – D7.1 Small-scale prototype of PHIRI federated infrastructure (2.2.4). Zenodo.
Was there any delay in the treatment of breast cancer patients because of the COVID-19 stringency measures?
F Estupiñán-Romero, J González-Galindo, N Martínez-Lizaga, J González-García, P Derycke, S Aldridge, A Faragalli, M Raimundo Maia, I Zile, E Bernal-Delgado, European Journal of Public Health, Volume 32, Issue Supplement_3, October 2022, ckac129.274
PHIRI – WP7 – Pilot outputs from the local analyses (interactive reports) (1.0.0)
Enrique Bernal-Delgado, Francisco Estupiñán-Romero, Javier González-Galindo, Carlos Tellería-Orriols, & Juan González-García. (2022). PHIRI – WP7 – Pilot outputs from the local analyses (interactive reports) (1.0.0). Zenodo.
PHIRI – WP7 – Pilot scripts for local analyses (RMarkdown) (1.0.0)
Enrique Bernal-Delgado, Francisco Estupiñán-Romero, Javier González-Galindo, Carlos Tellería-Orriols, & Juan González-García. (2022). PHIRI – WP7 – Pilot scripts for local analyses (RMarkdown) (1.0.0). Zenodo.
PHIRI – WP6 – Use Case D scripts for local analyses (R Markdown) (1.1.1)
Sarah Aldridge, Javier González-Galindo, Francisco Estupiñán-Romero, & Cesar Garriga. (2022). PHIRI – WP6 – Use Case D scripts for local analyses (R Markdown) (1.1.1).
PHIRI – WP6 – Use Case C scripts for local analyses (R Markdown) (2.0.1)
Marianne Philibert, Jennifer Zeitling, David Chichell-Ruiz, & Javier González-Galindo. (2022). PHIRI – WP6 – Use Case C scripts for local analyses (R Markdown) (2.0.1)
PHIRI – WP6 – Use Case B scripts for local analyses (R Markdown) (4.0.1)
Francisco Estupiñán-Romero, Javier González-Galindo, Natalia Martínez-Lizaga, & Enrique Bernal-Delgado. (2022). PHIRI – WP6 – Use Case B scripts for local analyses (R Markdown) (4.0.1). Zenodo.
PHIRI – WP6 – Use Case A scripts for local analyses (R Markdown) (1.1.2)
Sarah Aldridge, Javier González-Galindo, Francisco Estupiñán-Romero, & Lorenz Dolanski-Aghamanoukjan. (2022). PHIRI – WP6 – Use Case A scripts for local analyses (R Markdown) (1.1.2). Zenodo.
BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Common Data Model Specification
Estupiñán-Romero, Francisco, Van Goethem, Nina, Meurisse, Marjan, González-Galindo, Javier, & Bernal-Delgado, Enrique. (2022). BY-COVID – WP5 – Baseline Use Case: COVID-19 vaccine effectiveness assessment – Common Data Model Specification (1.0.0)